Vlijm A - Search Results

1

Encapsulating peritoneal sclerosis in patients on peritoneal dialysis.

Sampimon DE, Vlijm A, Struijk DG, Krediet RT. Sampimon DE, et al. Among authors: vlijm a. Neth J Med. 2008 Oct;66(9):396; author reply 397. Neth J Med. 2008. PMID: 18931402 Free article. No abstract available.

2

Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control study.

Vlijm A, Stoker J, Bipat S, Spijkerboer AM, Phoa SS, Maes R, Struijk DG, Krediet RT. Vlijm A, et al. Perit Dial Int. 2009 Sep-Oct;29(5):517-22. Perit Dial Int. 2009. PMID: 19776044

3

Encapsulating peritoneal sclerosis in a peritoneal dialysis patient using biocompatible fluids only: is Alport syndrome a risk factor?

Sampimon DE, Vlijm A, Phoa SS, Krediet RT, Struijk DG. Sampimon DE, et al. Among authors: vlijm a. Perit Dial Int. 2010 Mar-Apr;30(2):240-2. doi: 10.3747/pdi.2009.00087. Perit Dial Int. 2010. PMID: 20200369 No abstract available.

4

No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis: comments from around the world.

Sampimon DE, Vlijm A, Struijk DG, Krediet RT. Sampimon DE, et al. Among authors: vlijm a. Int Urol Nephrol. 2010 Mar;42(1):248-9. Int Urol Nephrol. 2010. PMID: 20355285 No abstract available.

5

Experimental peritoneal sclerosis models should not be based on chlorhexidine gluconate anymore.

Vlijm A, Sampimon DE, de Graaff M, Struijk DG, Krediet RT. Vlijm A, et al. Nephron Exp Nephrol. 2011;117(1):e1-8. doi: 10.1159/000319651. Epub 2010 Aug 4. Nephron Exp Nephrol. 2011. PMID: 20689329

6

A two-hit approach in the development of an experimental peritoneal sclerosis model.

Vlijm A, Sampimon DE, de Graaff M, Struijk DG, Krediet RT. Vlijm A, et al. Adv Perit Dial. 2012;28:26-31. Adv Perit Dial. 2012. PMID: 23311209

7

Effluent hydroxyproline in experimental peritoneal dialysis.

Vlijm A, de Waart DR, Zweers MM, Krediet RT. Vlijm A, et al. Perit Dial Int. 2007 Mar-Apr;27(2):210-3. Perit Dial Int. 2007. PMID: 17299162 No abstract available.

8

Biological markers in the peritoneal dialysate effluent: are they useful.

Krediet RT, Sampimon DE, Vlijm A, Coester AM, Struijk DG, Smit W. Krediet RT, et al. Among authors: vlijm a. Contrib Nephrol. 2009;163:54-59. doi: 10.1159/000223780. Epub 2009 Jun 3. Contrib Nephrol. 2009. PMID: 19494595 Review.

9

The effects of a dialysis solution with a combination of glycerol/amino acids/dextrose on the peritoneal membrane in chronic renal failure.

de Graaff M, Zegwaard AH, Zweers MM, Vlijm A, de Waart DR, Vandemaele F, Struijk DG, Krediet RT. de Graaff M, et al. Among authors: vlijm a. Perit Dial Int. 2010 Mar-Apr;30(2):192-200. doi: 10.3747/pdi.2008.00159. Epub 2010 Feb 1. Perit Dial Int. 2010. PMID: 20124192

10

Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study.

Sampimon DE, Korte MR, Barreto DL, Vlijm A, de Waart R, Struijk DG, Krediet RT. Sampimon DE, et al. Among authors: vlijm a. Perit Dial Int. 2010 Mar-Apr;30(2):163-9. doi: 10.3747/pdi.2009.00022. Epub 2010 Feb 1. Perit Dial Int. 2010. PMID: 20124195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters